Plasma protein binding of digitoxin and digoxin in several mammalian species.

Citations

1. Qiu F, Dziegielewska KM, Huang Y, Habgood MD, Fitzpatrick G, Saunders NR. Developmental changes in the extent of drug binding to rat plasma proteins. Sci Rep 2023 Jan 23;13(1):1266.
   doi: 10.1038/s41598-023-28434-1pubmed: 36690711google scholar: lookup
2. Eldawud R, Wagner A, Dong C, Gupta N, Rojanasakul Y, O'Doherty G, Stueckle TA, Dinu CZ. Potential antitumor activity of digitoxin and user-designed analog administered to human lung cancer cells. Biochim Biophys Acta Gen Subj 2020 Nov;1864(11):129683.
   doi: 10.1016/j.bbagen.2020.129683pubmed: 32679249google scholar: lookup
3. Eldawud R, Stueckle TA, Manivannan S, Elbaz H, Chen M, Rojanasakul Y, Dinu CZ. Real-time analysis of the effects of toxic, therapeutic and sub-therapeutic concentrations of digitoxin on lung cancer cells. Biosens Bioelectron 2014 Sep 15;59:192-9.
   doi: 10.1016/j.bios.2014.03.030pubmed: 24727605google scholar: lookup
4. Elbaz HA, Stueckle TA, Wang HY, O'Doherty GA, Lowry DT, Sargent LM, Wang L, Dinu CZ, Rojanasakul Y. Digitoxin and a synthetic monosaccharide analog inhibit cell viability in lung cancer cells. Toxicol Appl Pharmacol 2012 Jan 1;258(1):51-60.
   doi: 10.1016/j.taap.2011.10.007pubmed: 22037315google scholar: lookup
5. Bugyei K, Black WD, McEwen S. Pharmacokinetics of enrofloxacin given by the oral, intravenous and intramuscular routes in broiler chickens. Can J Vet Res 1999 Jul;63(3):193-200.
   pubmed: 10480461
6. Fichtl B, Doering W. The quinidine-digoxin interaction in perspective. Clin Pharmacokinet 1983 Mar-Apr;8(2):137-54.
   doi: 10.2165/00003088-198308020-00002pubmed: 6303672google scholar: lookup
7. Rasmussen F, Nawaz M, Steiness E. Renal excretion of digoxin in swine and goats. Acta Vet Scand 1975;16(4):525-36.
   doi: 10.1186/BF03546646pubmed: 1211330google scholar: lookup
8. Damm KH, Erttmann RR, Hoene R. Species differences in plasma binding and tissue uptake of 3H-digitoxin. A comparative study in rats and mice in vivo and in vitro. Naunyn Schmiedebergs Arch Pharmacol 1975;291(4):371-83.
   doi: 10.1007/BF00501795pubmed: 1207785google scholar: lookup
9. Perrier D, Mayersohn M, Marcus FI. Clinical pharmacokinetics of digitoxin. Clin Pharmacokinet 1977 Jul-Aug;2(4):292-311.
   doi: 10.2165/00003088-197702040-00005pubmed: 902449google scholar: lookup
10. Richter M, Haustein KO. Binding of 16alpha-gitoxin and its 16-acetate to human serum albumin. Eur J Clin Pharmacol 1977 Jul 19;11(6):459-61.
    doi: 10.1007/BF00562939pubmed: 891591google scholar: lookup
11. Verbeke N, Pellegrin P, Vienne A, Lesne M. The binding of gitoxin to human plasma proteins. Eur J Clin Pharmacol 1979 Nov;16(5):341-4.
    doi: 10.1007/BF00605633pubmed: 520402google scholar: lookup
12. Storstein L. Protein binding of cardiac glycosides in disease states. Clin Pharmacokinet 1977 May-Jun;2(3):220-33.
    doi: 10.2165/00003088-197702030-00006pubmed: 328208google scholar: lookup